{1}

##LOC[OK]## ##LOC[Cancel]##

{1}

##LOC[OK]## ##LOC[Cancel]##

1st Annual Mount Sinai MASLD/MASH (NAFLD/NASH) Center of Excellence Symposium

Overview
Register
Faculty
Brochure

Add to Calendar 1st Annual Mount Sinai MASLD/MASH (NAFLD/NASH) Center of Excellence Symposium 10/6/2023 8:00:00 AM 10/6/2023 4:15:00 PM America/New_York For More Details: https://mssm.cloud-cme.com/NASH Description: This symposium will provide a comprehensive overview of the diagnosis, risk stratification, management including co-morbidities, and emerging therapies for MASLD/MASH (NAFLD/NASH) Online false MM/DD/YYYY

Date & Location

Friday, October 6, 2023, 8:00 AM - 4:15 PM, Online

Target Audience

Specialties - Liver Diseases, Multiple Specialties

Professions - Non-Physician, Nurse, Physician

Course Overview

This symposium will provide a comprehensive overview of the diagnosis, risk stratification, management including co-morbidities, and emerging therapies for MASLD/MASH (NAFLD/NASH)

Objectives

Recognizse NAFLD/NASH clinical course, risk stratification, outcomes, and management.
Interpret and appropriately apply results of non-invasive tests for NAFLD/NASH to diverse patient populations.

Registration

First 300 registrants are complimentary!

Accreditation

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credits

AMA PRA Category 1 Credits™ (6.50 hours), Non-Physician Attendance (6.50 hours)

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

Icahn School of Medicine at Mount Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Anna Mageras, MPH
Mount Sinai
Sunnyside, NY

Co-Director

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Gilead (Relationship has ended)

Meena B. Bansal, MD

Professor of Medicine
Icahn School of Medicine at Mount Sinai
New York, NY

Course Director, Faculty

Advisor-Intercept, Madrigal, NovoNordisk, Fibronostics, The Kinetix Group|Consulting Fee-Intercept, Madrigal, NovoNordisk, Fibronostics|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Intercept, Madrigal, NOVO Nordisk|Grant or research support-Histoindex, Pfizer

Manal F Abdelmalek, MD, MPH, Professor of Medicine
Director, NAFLD Clinical Research
Mayo Clinic
Rochester, MN

Faculty

Consulting Fee-Hanmi|Consulting Fee-Novo Nordisk|Advisor-89 Bio|Advisor-Madrigal|Advisor-Merck (Relationship has ended)|Advisor-Inventiva|Advisor-Intercept Pharmaceuticals|Grant or research support-Madrigal|Grant or research support-Gilead|Grant or research support-Novo Nordisk|Grant or research support-Inventiva|Grant or research support-Hanmi|Grant or research support-89 Bio (Relationship has ended)|Grant or research support-Durect (Relationship has ended)|Grant or research support-Galmed Galmed (Relationship has ended)|Grant or research support-Genentech Genentech (Relationship has ended)|Grant or research support-TARGET Pharma (Relationship has ended)|Grant or research support-Celgene (Relationship has ended)|Grant or research support-Intercept Pharmaceuticals (Relationship has ended)|Honoraria-Clinical Care Options, Fishawack, Inc, Medscape, Terra Firma, Inc, CLDF|Honoraria-Fishawack Inc, LLC|Honoraria-Terra Firma, LLC|Honoraria-Medscape|Honoraria-Clinical Care Options (Relationship has ended)

Naim Alkhouri, MD
Chief Medical Officer
Arizona Liver Health
PHOENIX, AZ

Faculty

Grant or research support-Madrigal|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Madrigal|Grant or research support-89 Bio|Grant or research support-Boehringer Ingelheim Boehringer Ingelheim|Grant or research support-Merck|Grant or research support-Gilead|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Pfizer|Speakers Bureau-Intercept Pharmaceuticals|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novo Nordisk|Grant or research support-Novo Nordisk

Alina M Allen, MD, Dr
Director SLD Clinic
Mayo Clinic
Rochester, MN

Faculty

Grant or research support-Novo Nordisk|Grant or research support-Pfizer (Relationship has ended)

Andrea Branch, PhD
New York, NY

Faculty

Nothing to disclose

Jaime Chu, MD
Icahn School of Medicine at Mount Sinai
Manhasset, NY

Faculty

Consulting Fee-Albireo

Kathleen Corey, MD
Associate Professor
Massachusetts General Hospital
Somerville, MA

Faculty

Advisor-Theratechnologies (Relationship has ended)|Advisor-Intercept (Relationship has ended)|Advisor-Medscape|Advisor-Sagimet (Relationship has ended)|Advisor-Astrazeneca (Relationship has ended)

Scott L. Friedman, MD

Fishberg Professor of Medicine, Liver Diseases and Pharmacological Sciences
Icahn School of Medicine a Mount Sinai
New York, NY

Faculty

Stephen A. Harrison, MD
Pinnacle Clinical Reserach
San Antonio, TX

Faculty

Stocks or stock options, excluding diversified mutual funds-Akero Therapeutics, Chronwell, Cirius, Galectin, Genfit, Hepion, Hepta Bio, HistoIndex, Metacrine, NGM Bio, Northsea, Sonic Incytes |Consulting Fee-Akero Therapeutics, Aligos, Altimmune, Arrowhead, Bluejay Therapeutics, Boxer Capital, Chronwell, Echosens, Enyo, Foresite Labs, Galectin, Galecto, Gilead, GSK, Hepagene, Hepion, Hepta Bio, HistoIndex,Humana, Intercept, Ionis, Madrigal, Medpace, NeuroBo Pharmaceuticals, Northsea, Novo Nordisk, Perspectum, Pfizer, Sonic Incytes, Sagimet, Terns, Viking|Grant or research support-Akero Therapeutics, Altimmune, Axcella, BMS, Corcept, Cymabay, Enyo, Galectin, Genentech, Genfit, Gilead, GSK, Hepion, Hightide, Immuron, Intercept, Inventiva, Ionis, Madrigal, NGM Bio, Novartis, Novo Nordisk, Northsea, Pfizer, Poxel, Sagimet, Terns, Viking

Tatyana Kushner, MD

Assistant Professor of Medicine
Icahn School of Medicine at Mount Sinai
New York, NY

Faculty

Advisor-Gilead|Grant or research support-Gilead|Advisor-Salix

Mazen Noureddin, MD
Houston Methodist Hospital
Houston, TX

Faculty

Advisor-Altimmune, BI, Cytodyn, 89BIO, GSK, Madrigal, Merck, Novo Nordisk, Perspectum, Siemens, Terns and Takeda. (Relationship has ended)|Grant or research support-Allergan, Akero, BMS, Gilead, Galectin, Genfit, GSK, Conatus, Corcept, Enanta, Madrigal, Novartis, Novo Nordisk, Shire, Takeda, Terns, Viking and Zydus. (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-Rivus Pharma, CIMA, Cytodyn, and ChronWell

Mary Rinella, MD
Professor of Medicine
University of Chicago Medicine
Chicago, IL

Faculty

Consulting Fee-Boehringer Ingelheim Boehringer Ingelheim|Consulting Fee-Intercept Pharmaceuticals|Consulting Fee-Madrigal|Consulting Fee-Novo-Nordisk|Consulting Fee-Pfizer

Reshmi Srinath, MD
Assistant Professor of Medicine, Endocrinology
Icahn School of Medicine at Mount Sinai
New York, NY

Faculty

Grant or research support-Eli Lilly & Co.|Grant or research support-Dexcom

Augusto Villanueva, MD, PhD
Associate Professor, Liver Diseases, Hematology and Medical Oncology
Icahn School of Medicine at Mount Sinai
New York, NY

Faculty

Friday, October 6, 2023

The BIG Picture: Non-Alcoholic Steatohepatitis/Metabolic Dysfunction Associated Steatohepatitis (NASH/MASH)
8:00AM - 8:30AM
Scott L. Friedman, MD

What’s in a Name? From NAFLD/NASH to MASLD/MASH: Nomenclature Changes and Potential Impact on Providers, Patients, Pharmaceutical Companies, and Regulatory Agencies
8:30AM - 8:50AM
Mary Rinella, MD

Cracking the Code: Making the Diagnosis, Risk Stratification, and Prognosis Prediction in MASLD/MASH
8:50AM - 9:10AM
Manal F Abdelmalek, MD, MPH, Professor of Medicine

It’s Complicated: Metabolic Dysfunction and MASLD/MASH
9:10AM - 9:40AM
Andrea Branch, PhD

The Clues Within: Overview of Serum Markers of Liver Fibrosis and Metabolic Health
9:40AM - 10:00AM
Mazen Noureddin, MD

Break
10:00AM - 10:15AM

Seeing is Believing: Overview of Imaging Modalities for the Assessment of MASLD/MASH
10:15AM - 10:35AM
Alina M Allen, MD, Dr

Powering the Future: Leveraging New AI and Imaging Technologies for Intelligent Augmentation
10:35AM - 10:55AM
Naim Alkhouri, MD

Eye of the Storm: Intersection of Genetics, Lifestyle, and Environment in Pediatric MASLD/MASH
10:55AM - 11:15AM
Jaime Chu, MD

Catch Me When You Can: Maximizing Opportunities for Engagement by Screening for MASLD/MASH in OB/GYN
11:15AM - 11:35AM
Tatyana Kushner, MD

Don’t You Forget About Me: MASLD/MASH in Special Populations
11:35AM - 12:00PM
Meena B. Bansal, MD

Lunch and Sponsor Booths
12:00PM - 1:00PM

Empowering Change: Lifestyle, Medical, and Surgical Management of Obesity and Diabetes, and their Role in the Management of Patients with MASLD/MASH
1:00PM - 1:30PM
Reshmi Srinath, MD

Finding a Needle in a Haystack: MASLD/MASH and HCC
1:30PM - 1:50PM
Augusto Villanueva, MD, PhD

Can I Get a Drum Roll, Please? Approved and Emerging Therapies for NASH (MASH)
1:50PM - 2:20PM
Stephen A. Harrison, MD

The Crystal Ball: Predicting and Managing Cardiovascular Risk in Patients with MASLD/MASH
2:20PM - 2:40PM
Kathleen Corey, MD

Break
2:40PM - 3:00PM

Ask The Experts: Making Sense of It All (Case-Based Discussion and Q&A) All Faculty
3:00PM - 4:00PM

Closing Remarks
4:00PM - 4:15PM